ORMP: Oramed Pharmaceuticals Inc. Stock

by  •  • Comments Off on ORMP: Oramed Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 101.18
Enterprise Value ($M) 58.16
Book Value ($M) 155.52
Book Value / Share 3.86
Price / Book 0.65
NCAV ($M) 133.22
NCAV / Share 3.30
Price / NCAV 0.76

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.03

Liquidity (mrq)
Quick Ratio 27.08
Current Ratio 27.08

Balance Sheet (mrq) ($M)
Current Assets 142.77
Assets 165.08
Liabilities 9.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A BML Investment Partners, L.P. 6.55 29.06
03-22 13D Kidron Nadav 5.70 74.47

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 38,173 223,222 17.10
2025-03-10 59,588 258,878 23.02
2025-03-07 57,842 354,155 16.33
2025-03-06 29,894 264,716 11.29

(click for more detail)

Similar Companies
ONCY – Oncolytics Biotech Inc. ONVO – Organovo Holdings, Inc.
ORGO – Organogenesis Holdings Inc. OTLK – Outlook Therapeutics, Inc.
PALI – Palisade Bio, Inc.


Financial data and stock pages provided by
Fintel.io